Cargando…

Using Electronic Health Record Data to Identify Prostate Cancer Patients That May Qualify for Active Surveillance

INTRODUCTION: The introduction of the protein-specific antigen (PSA) test in care means that prostate cancer (PCa) is being detected earlier and more frequently. The result of increased screening using PSA, digital rectal examination and awareness of prostate was an increase in the number of men wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Knighton, Andrew J., Belnap, Tom, Brunisholz, Kim, Huynh, Kelly, Bishoff, Jay T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AcademyHealth 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019322/
https://www.ncbi.nlm.nih.gov/pubmed/27683663
http://dx.doi.org/10.13063/2327-9214.1220
_version_ 1782453037035421696
author Knighton, Andrew J.
Belnap, Tom
Brunisholz, Kim
Huynh, Kelly
Bishoff, Jay T.
author_facet Knighton, Andrew J.
Belnap, Tom
Brunisholz, Kim
Huynh, Kelly
Bishoff, Jay T.
author_sort Knighton, Andrew J.
collection PubMed
description INTRODUCTION: The introduction of the protein-specific antigen (PSA) test in care means that prostate cancer (PCa) is being detected earlier and more frequently. The result of increased screening using PSA, digital rectal examination and awareness of prostate was an increase in the number of men with low risk cancers. Active surveillance has become a viable alternative to immediate treatment with surgery, radiation and other forms of localized treatment. Evidence suggests that there is no significant difference in mortality rates between AS and surgery. In addition, patients may potentially delay other complications associated with surgery, radiation or deprivation therapy. METHODS: This quality improvement study using a delivery system science framework describes the electronic identification of AS candidates given an evidence-based identification criteria based upon national guidelines and clinical judgement. The study population (n=649) was drawn from health records of all patients who received a prostate biopsy (n=1731) at Intermountain Healthcare from 1/1/2013 to 12/31/2014. Automated and manual abstraction was performed. Receiver operating characteristic (ROC) analysis was used to compare AS-eligible patients to the actual treatment received to identify potential care improvement opportunities. Among those with complete data, 24.7% of this population (n=160) met “AS-eligible” criteria. 39.1% of the population had not received surgery, radiation or androgen deprivation therapy and were considered as being treated using an AS approach. 9% of AS-eligible patients did not receive AS; 27% of patients who did not meet AS-eligible criteria received AS. Estimated guideline adherence measured using area under the curve was 0.70 (95% CI: 0.66–0.73). Modest variation in criteria parameters for identifying AS-eligible patients did not significantly change estimated adherence levels. CONCLUSION: Implementation of evidence-based criteria for detection of AS candidates is feasible using electronic health record data and provides a reasonable basis for delivery system evaluation of practice patterns and for quality improvement.
format Online
Article
Text
id pubmed-5019322
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher AcademyHealth
record_format MEDLINE/PubMed
spelling pubmed-50193222016-09-28 Using Electronic Health Record Data to Identify Prostate Cancer Patients That May Qualify for Active Surveillance Knighton, Andrew J. Belnap, Tom Brunisholz, Kim Huynh, Kelly Bishoff, Jay T. EGEMS (Wash DC) Articles INTRODUCTION: The introduction of the protein-specific antigen (PSA) test in care means that prostate cancer (PCa) is being detected earlier and more frequently. The result of increased screening using PSA, digital rectal examination and awareness of prostate was an increase in the number of men with low risk cancers. Active surveillance has become a viable alternative to immediate treatment with surgery, radiation and other forms of localized treatment. Evidence suggests that there is no significant difference in mortality rates between AS and surgery. In addition, patients may potentially delay other complications associated with surgery, radiation or deprivation therapy. METHODS: This quality improvement study using a delivery system science framework describes the electronic identification of AS candidates given an evidence-based identification criteria based upon national guidelines and clinical judgement. The study population (n=649) was drawn from health records of all patients who received a prostate biopsy (n=1731) at Intermountain Healthcare from 1/1/2013 to 12/31/2014. Automated and manual abstraction was performed. Receiver operating characteristic (ROC) analysis was used to compare AS-eligible patients to the actual treatment received to identify potential care improvement opportunities. Among those with complete data, 24.7% of this population (n=160) met “AS-eligible” criteria. 39.1% of the population had not received surgery, radiation or androgen deprivation therapy and were considered as being treated using an AS approach. 9% of AS-eligible patients did not receive AS; 27% of patients who did not meet AS-eligible criteria received AS. Estimated guideline adherence measured using area under the curve was 0.70 (95% CI: 0.66–0.73). Modest variation in criteria parameters for identifying AS-eligible patients did not significantly change estimated adherence levels. CONCLUSION: Implementation of evidence-based criteria for detection of AS candidates is feasible using electronic health record data and provides a reasonable basis for delivery system evaluation of practice patterns and for quality improvement. AcademyHealth 2016-08-10 /pmc/articles/PMC5019322/ /pubmed/27683663 http://dx.doi.org/10.13063/2327-9214.1220 Text en All eGEMs publications are licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License http://creativecommons.org/licenses/by-nc-nd/3.0/
spellingShingle Articles
Knighton, Andrew J.
Belnap, Tom
Brunisholz, Kim
Huynh, Kelly
Bishoff, Jay T.
Using Electronic Health Record Data to Identify Prostate Cancer Patients That May Qualify for Active Surveillance
title Using Electronic Health Record Data to Identify Prostate Cancer Patients That May Qualify for Active Surveillance
title_full Using Electronic Health Record Data to Identify Prostate Cancer Patients That May Qualify for Active Surveillance
title_fullStr Using Electronic Health Record Data to Identify Prostate Cancer Patients That May Qualify for Active Surveillance
title_full_unstemmed Using Electronic Health Record Data to Identify Prostate Cancer Patients That May Qualify for Active Surveillance
title_short Using Electronic Health Record Data to Identify Prostate Cancer Patients That May Qualify for Active Surveillance
title_sort using electronic health record data to identify prostate cancer patients that may qualify for active surveillance
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019322/
https://www.ncbi.nlm.nih.gov/pubmed/27683663
http://dx.doi.org/10.13063/2327-9214.1220
work_keys_str_mv AT knightonandrewj usingelectronichealthrecorddatatoidentifyprostatecancerpatientsthatmayqualifyforactivesurveillance
AT belnaptom usingelectronichealthrecorddatatoidentifyprostatecancerpatientsthatmayqualifyforactivesurveillance
AT brunisholzkim usingelectronichealthrecorddatatoidentifyprostatecancerpatientsthatmayqualifyforactivesurveillance
AT huynhkelly usingelectronichealthrecorddatatoidentifyprostatecancerpatientsthatmayqualifyforactivesurveillance
AT bishoffjayt usingelectronichealthrecorddatatoidentifyprostatecancerpatientsthatmayqualifyforactivesurveillance